Veradermics, Inc. (MANE)
102.23
+3.77
(+3.83%)
USD |
NYSE |
Aug 25, 16:00
102.23
0.00 (0.00%)
After-Hours: 17:04
Veradermics Total Assets (Quarterly) : 826.33M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 826.33M |
| March 31, 2026 | 398.58M |
| December 31, 2025 | 154.47M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 59.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| EyePoint, Inc. | 228.19M |
| Elanco Animal Health, Inc. | 13.56B |
| Tarsus Pharmaceuticals, Inc. | 611.14M |
| Amylyx Pharmaceuticals, Inc. | 264.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.12M |
| Shareholders Equity (Quarterly) | 814.21M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 70.53 |
| Net Debt Paydown Yield | -0.00% |